AnaptysBio Announces 2024 Annual Meeting of Stockholders on June 12

TL;DR

<b>AnaptysBio is holding its 2024 Annual Meeting of Stockholders on June 12, 2024, and is utilizing internet delivery of proxy materials.</b>

AI Summary

ANAPTYSBIO, INC (ANAB) filed a Proxy Statement (DEF 14A) with the SEC on April 24, 2024. AnaptysBio, Inc. will hold its 2024 Annual Meeting of Stockholders on June 12, 2024, at 7:30 a.m. Pacific Time. The meeting will take place at AnaptysBio's corporate office located at 10770 Wateridge Circle, Suite 210, San Diego, CA 92121. Proxy materials will be furnished to stockholders over the Internet, with a Notice of Internet Availability expected to be mailed around April 24, 2024. Stockholders can vote via the Internet, telephone, or by requesting and returning a proxy card. The filing is a Definitive Proxy Statement (DEF 14A) filed on April 24, 2024.

Why It Matters

For investors and stakeholders tracking ANAPTYSBIO, INC, this filing contains several important signals. This filing is a routine proxy statement, indicating the company is preparing for its annual shareholder meeting to discuss corporate governance and other business matters. The company's decision to furnish proxy materials over the internet aims to reduce costs and environmental impact, a common practice for publicly traded companies.

Risk Assessment

Risk Level: low — ANAPTYSBIO, INC shows low risk based on this filing. The risk is low as this is a standard DEF 14A filing for an annual meeting, with no immediate financial or operational disclosures beyond the meeting logistics.

Analyst Insight

Stockholders should review the proxy materials to understand the proposals being voted on and ensure their vote is cast before the June 12, 2024 meeting.

Key Numbers

• 2024 — Annual Meeting Year (2024 Annual Meeting of Stockholders)
• June 12 — Meeting Date (Wednesday, June 12, 2024)
• 7:30 a.m. (Pacific Time) — Meeting Time (7:30 a.m. (Pacific Time))
• 2023 — Fiscal Year End (Annual report on Form 10-K for the year ended December 31, 2023)

Key Players & Entities

• ANAPTYSBIO, INC. (company) — Registrant
• Daniel Faga (person) — President and Chief Executive Officer
• June 12, 2024 (date) — Date of Annual Meeting
• April 24, 2024 (date) — Filing Date / Mailing Date of Notice
• 10770 Wateridge Circle, Suite 210, San Diego, CA 92121 (location) — Corporate Office Address

FAQ

Industry Context

AnaptysBio, Inc. operates in the pharmaceutical preparations industry, focusing on developing novel therapeutic proteins.

Regulatory Implications

The filing adheres to SEC regulations for proxy statements (Schedule 14A) under the Securities Exchange Act of 1934, ensuring transparent communication with shareholders.

What Investors Should Do

1. Review the proxy statement for details on proposals and director nominations.
2. Vote your shares via internet, phone, or mail by the meeting date.
3. Attend the annual meeting on June 12, 2024, if possible.

Key Dates

• 2024-06-12: 2024 Annual Meeting of Stockholders — Key date for shareholder voting and company business review.
• 2024-04-24: Filing Date of DEF 14A — Indicates the proxy materials are officially filed with the SEC.
• 2024-04-24: Expected Mailing Date of Notice of Internet Availability — Date stockholders will be notified to access proxy materials online.

Year-Over-Year Comparison

This is a DEF 14A filing for the 2024 annual meeting, following the typical schedule for such corporate events.

Key Financial Figures

• $250 million — ares held by non-affiliates is at least $250 million measured on the last business day of ou
• $100 million — er, or our annual revenues are at least $100 million during the most recently completed fisc
• $700 million — ares held by non-affiliates is at least $700 million measured on the last business day of ou

Filing Documents

• proxystatementfy2023_def14a.htm (DEF 14A) — 787KB
• anaptysbioproxycard_1.jpg (GRAPHIC) — 1299KB
• anaptysbioproxycard_2.jpg (GRAPHIC) — 202KB
• compensationvsnetincomev2.jpg (GRAPHIC) — 77KB
• compensationvstsrv2.jpg (GRAPHIC) — 76KB
• dfsignature.jpg (GRAPHIC) — 4KB
• johnorwinsignature.jpg (GRAPHIC) — 6KB
• newlogo.jpg (GRAPHIC) — 49KB
• 0001370053-24-000019.txt (&nbsp;) — 3145KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 27 EXECUTIVE OFFICERS 29

EXECUTIVE COMPENSATION TABLES

EXECUTIVE COMPENSATION TABLES 38 EQUITY COMPENSATION PLAN INFORMATION 46 CERTAIN RELATIONSHIPS AND RELATED-PARTY TRANSACTIONS 47 ADDITIONAL INFORMATION 48 OTHER MATTERS 50 ANNEX A 51 i ANAPTYSBIO, INC. 10770 Wateridge Circle, Suite 210 San Diego, California 92121 PROXY STATEMENT FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS To Be Held Wednesday, June 12, 2024 INFORMATION ABOUT SOLICITATION AND VOTING The accompanying proxy is solicited on behalf of AnaptysBio, Inc.'s board of directors ("Board") for use at AnaptysBio's 2024 Annual Meeting of Stockholders ("Annual Meeting") to be held at AnaptysBio's corporate office at 10770 Wateridge Circle, Suite 210, San Diego, California 92121, on Wednesday, June 12, 2024 at 730 a.m. (Pacific Time), and any adjournment or postponement thereof. INTERNET AVAILABILITY OF PROXY MATERIALS Under rules adopted by the Securities and Exchange Commission ("SEC"), we are furnishing proxy materials to our stockholders primarily via the Internet, instead of mailing printed copies to each stockholder. On or about April 24, 2024, we expect to send to our stockholders a Notice of Internet Availability of Proxy Materials containing instructions on how to access our proxy materials, including our proxy statement and our annual report on Form 10-K. The Notice of Internet Availability of Proxy Materials also provides instructions on how to vote through the Internet or by telephone and includes instructions on how to receive paper copies of the proxy materials by mail or an electronic copy of the proxy materials by email. This process is designed to reduce our environmental impact and lower the costs of printing and distributing our proxy materials without impacting our stockholders' timely access to this important information. However, if you would prefer to receive printed proxy materials, please follow the instructions included in the Notice of Internet Availability. GENERAL INFORMATION ABOUT THE MEETING Purpose o

View Full Filing

View this DEF 14A filing on SEC EDGAR